Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06605144 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Canadian Critical Care Comparative Effectiveness Platform

Study acronym: CEPEC
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 9 to 11 Show 4 more changesShow less
    • Interventions: 1- Platelet less than 10 x 109/L (Other), 1- Vasopressor - Mean arterial pressure 56-60 (Drug), 2- Platelet less than 20 x 109/L (Other)… to 1- Platelet less than 10 x 109/L (Other), 1- Vasopressor - Mean arterial pressure 56-60 (Drug), 2- Platelet less than 20 x 109/L (Other)…
    • Eligibility criteria expanded, about 17 words
    • Secondary endpoints: details revised at 3 of 15 entries
    • Study description expanded, about 104 words
  2. Collaborators expanded, about 4 wordsv9
  3. Study sites: 8 to 9
    • Eligibility criteria expanded, about 2 words
    v8
  4. Primary endpoints revised (3)
    • Eligibility criteria revised
    • Site details revised at 1 of 8 sites
    v7
  5. Primary endpoints: 2 to 3v6 Show 7 more changesShow less
    • Enrollment target: 6900 to 5500
    • Interventions: 1- Platelet less than 10 x 109/L (Other), 1- Vasopressor - Mean arterial pressure 56-60 (Drug), 2- Platelet less than 20 x 109/L (Other)… to 1- Platelet less than 10 x 109/L (Other), 1- Vasopressor - Mean arterial pressure 56-60 (Drug), 2- Platelet less than 20 x 109/L (Other)…
    • Eligibility criteria expanded, about 92 words
    • Secondary endpoints: 12 to 15
    • Study description expanded, about 78 words
    • Site details revised at 5 of 8 sites
    • Study arms: 2 to 3
Show 4 earlier versionsHide 4 earlier versions
  1. Phase: Not applicable to Phase 3v5 Show 9 more changesShow less
    • Primary endpoints: 1 to 2
    • Enrollment target: 6500 to 6900
    • Study sites: 1 to 8
    • Start date: Mar 17, 2025 to Mar 23, 2025
    • Interventions: 1- Vasopressors - Mean arterial pressure 56-60 (Other), 2- Vasopressors - Mean arterial pressure 61-65 (Other), 3- Vasopressors - Mean… to 1- Platelet less than 10 x 109/L (Other), 1- Vasopressor - Mean arterial pressure 56-60 (Drug), 2- Platelet less than 20 x 109/L (Other)…
    • Eligibility criteria expanded, about 54 words
    • Secondary endpoints: 5 to 12
    • Study description expanded, about 83 words
    • Study arms: 1 to 2
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Mar 26, 2025 to Mar 17, 2025
    v4
  3. Start date: Jan 2, 2025 to Mar 26, 2025
    • Interventions: 1- Vasopressors - Mean arterial pressure 55-59 (Other), 2- Vasopressors - Mean arterial pressure 60-65 (Other), 3- Vasopressors - Mean… to 1- Vasopressors - Mean arterial pressure 56-60 (Other), 2- Vasopressors - Mean arterial pressure 61-65 (Other), 3- Vasopressors - Mean…
    • Eligibility criteria expanded, about 65 words
    v3
  4. Study description expanded, about 1 wordv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Canadian Critical Care Comparative Effectiveness Platform(e) d'Évaluation Clinique Comparée en soins Critiques (CEPEC) is an international multi-centered randomized adaptive platform clinical trial. CEPEC will evaluate supportive care interventions that are used routinely in intensive care units throughout the world.
Trial Details
NCT Number NCT06605144
Lead Sponsor Université de Sherbrooke
Collaborators: Hamilton Health Sciences Corporation
Conditions
(from sponsor)		 Intensive Care Unit ICU, Vasopressor, Platelet, Nutrition
Enrollment 5,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov